We are on the ground in San Diego! Follow us on Twitter for more updates: @damiangarde@rebeccadrobbins@megkesh, and of course, @statnews

Making up for past snubs

Massachusetts Gov. Charlie Baker raised eyebrows when he skipped BIO last year — and the year before. But he’s not taking the industry for granted any more. He’s coming to town to talk up his new five-year, $500 million biopharma initiative(which is basically an extension of his predecessor’s 10-year, $1 billion program to promote life sciences). He’ll also be trying to get a sense of how these BIO bashes work: Boston is slated to host next year’s confab.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy